Ars Pharmaceuticals is expanding its $199 neffy retail access program while awaiting a crucial decision from CVS Caremark, aiming to boost affordability...
Figma reported strong Q1 2026 results, beating revenue expectations and raising its full-year outlook, despite initial market fears that AI design tools...
Byrna Technologies Inc. (BYRN) shares entered oversold territory on Friday, with its Relative Strength Index (RSI) falling to 28.5.
As the SEC considers semiannual reporting, leading companies demonstrate diverse, effective strategies for quarterly disclosures. These approaches prioritize transparency and investor engagement...
Stocks and bonds declined globally as rising oil prices deepened inflation concerns and investors reassessed the longevity of the artificial intelligence rally....
Mudita Advisor has acquired a significant stake in Core Natural Resources (CNR), a move that contrasts with the company's recent market underperformance.
Nebius Group's shares surged Wednesday following an enhanced artificial intelligence growth outlook, driven by soaring demand for high-performance compute.
The upcoming SpaceX IPO, alongside other trillion-dollar offerings, highlights a profound shift in market dynamics, raising concerns about traditional capitalism and index...
Global shares mostly declined Tuesday, driven by escalating Iran war concerns and surging oil prices, despite a recent Wall Street rally. Pessimism...